geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Veterinary Medicine Needs New Green Antimicrobial Drugs


, : Veterinary Medicine Needs New Green Antimicrobial Drugs. Frontiers in Microbiology 7: 1196-1196

Given that: (1) the worldwide consumption of antimicrobial drugs (AMDs) used in food-producing animals will increase over the coming decades; (2) the prudent use of AMDs will not suffice to stem the rise in human antimicrobial resistance (AMR) of animal origin; (3) alternatives to AMD use are not available or not implementable, there is an urgent need to develop novel AMDs for food-producing animals. This is not for animal health reasons, but to break the link between human and animal resistomes. In this review we establish the feasibility of developing for veterinary medicine new AMDs, termed "green antibiotics," having minimal ecological impact on the animal commensal and environmental microbiomes. We first explain why animal and human commensal microbiota comprise a "turnstile" exchange, between the human and animal resistomes. We then outline the ideal physico-chemical, pharmacokinetic, and pharmacodynamic properties of a veterinary green antibiotic and conclude that they can be developed through a rational screening of currently used AMD classes. The ideal drug will be hydrophilic, of relatively low potency, slow clearance and small volume of distribution. It should be eliminated principally by the kidney as inactive metabolite(s). For oral administration, bioavailability can be enhanced by developing lipophilic pro-drugs. For parenteral administration, slow-release formulations of existing eco-friendly AMDs with a short elimination half-life can be developed. These new eco-friendly veterinary AMDs can be developed from currently used drug classes to provide alternative agents to those currently used in veterinary medicine and mitigate animal contributions to the human AMR problem.

US$19.90

PMID: 27536285

DOI: 10.3389/fmicb.2016.01196


Other references

Srinivasa, R.N.; Chick, J.Forris.Beecham.; Hage, A.; Ramamurthi, A.; Wolf, J.Stuart.; Gemmete, J.J.; Dauw, C.A., 2017: Erosion of Embolization Coils into the Renal Collecting System: Removal with Prone Transradial Renal Arteriography and Nephroscopy. Removal of embolization coils eroded into the renal collecting system poses a risk of hemorrhage, which may need to be addressed with arteriography and embolization at the time of treatment. The purpose of this report is to describe a novel approa...

Gruppen, L.D., 2014: Humility and respect: core values in medical education. Many of the values and behaviours described in the original Hippocratic Oath are relevant to medical education. In particular, the values of intellectual humility and respect for one's colleagues are essential in all scientific disciplines. T...

Titov V.B.; Savin M.T., 2000: Spectral characteristics of age series of surface air temperature in Black Sea region. Air temperature spectra based on mean monthly values for 100 year period of observation on 13 hydrometeoro-logical stations in Black Sea have been calculated. The coincidence of the fluctuation periods for the whole region is fixed on monthly spec...

Karp, J.E.; Blackford, A.; Smith, B.Douglas.; Alino, K.; Seung, A.Hatfield.; Bolaños-Meade, J.; Greer, J.M.; Carraway, H.E.; Gore, S.D.; Jones, R.J.; Levis, M.J.; McDevitt, M.A.; Doyle, L.Austin.; Wright, J.J., 2010: Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia. Flavopiridol, a cyclin-dependent kinase inhibitor, is cytotoxic to leukemic blasts. In a Phase II study, flavopiridol 50 mg/m(2) was given by 1-h infusion daily x 3 beginning day 1 followed by 2 g/m(2)/72 h ara-C beginning day 6 and 40 mg/m(2) mit...

Varroud Vial, M.; Bauduceau, B.; Attali, C.; Attali, J.R.; Charpentier, G.; Bailleau, C.; Kleinebreil, L.; Preiss, P.; Vaur, L.; Viguier Petit, C.; Eschwege, E., 2003: DIASTEP Improvement of management and outcomes of patient with Type 2 diabetes A national audit undertaken by 1631 French GPs. Diabetologia 46(Supplement 2): A99-A100, August

Wilczek, Rudolf, 1948: Le genre Dicranum Hedw en Belgique. A revision of the genus in Belgium, with key to the spp. and vars., descr., review of literature, synonymy, and geographic distr. for each sp. D. undulatum: P. bonjeani with var. polycladum, D. spurium; P. scoparium with vars. recurvatum, paludosu...

Singer, W.; Joyner, M.J.; Sandroni, P.; Benarroch, E.E.; Fealey, R.D.; Mandrekar, J.; Low, P.A., 2015: Midodrine efficacy in orthostatic hypotension. Journal of General Internal Medicine 29(11): 1440-1441

Pellissier, Lïc.; Oppliger, A.; Hirzel, A.H.; Savova-Bianchi, D.; Mbayo, G.; Mascher, F.; Kellenberger, S.; Niculita-Hirzel, Hélène., 2016: Airborne and Grain Dust Fungal Community Compositions Are Shaped Regionally by Plant Genotypes and Farming Practices. Chronic exposure to airborne fungi has been associated with different respiratory symptoms and pathologies in occupational populations, such as grain workers. However, the homogeneity in the fungal species composition of these bioaerosols on a lar...

Sistovaris, N., 1983: Quantitative thin-layer chromatography for routine determination of nomifensine and its metabolites in human urine. For pharmacokinetic studies with nomifensine, a thin-layer chromatographic (TLC) assay for human urine was introduced. Following acid cleavage of the N-glucuronides, nomifensine and its three main metabolites (M1, M2 and M3) were extracted at pH 1...

Middlebrook, Gardner, 1954: Isoniazid-resistance and catalase activity of tubercle bacilli. Strains of virulent tubercle bacilli resistant to isoniazid in vitro, and whose pathogenicity for guinea pigs has been attenuated, manifested no catalase activity in vitro either in the presence or absence of isoniazid.